
Sign up to save your podcasts
Or
Join us on PROSTATE CANCER: REAL TALK as we sit down with Dr. Deville, Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins University School of Medicine. He also serves as the Medical Director of the Johns Hopkins Proton Therapy Center and the Clinical Director and Chair of Sibley Radiation Oncology.
In this episode, Dr. Deville breaks down the latest advancements in radiation oncology for prostate cancer treatment, from cutting-edge proton therapy to modern precision-based methods designed to better target tumors while minimizing side effects. With more than 170 peer-reviewed publications and a career dedicated to advancing cancer care, he provides a clear look into how radiation therapy is evolving to improve patient outcomes.
Beyond the science, Dr. Deville also highlights his passion for Health Equity, Diversity, and Inclusion (HEDI), sharing his role on the ASTRO Council on HEDI and his recent election to the ASTRO Board of Directors.
Tune in to gain a deeper understanding of the future of prostate cancer treatment and how these innovations—and Dr. Deville’s leadership—are shaping a more effective and equitable approach to care.
www.prostatecancerrealtalk.com
5
22 ratings
Join us on PROSTATE CANCER: REAL TALK as we sit down with Dr. Deville, Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins University School of Medicine. He also serves as the Medical Director of the Johns Hopkins Proton Therapy Center and the Clinical Director and Chair of Sibley Radiation Oncology.
In this episode, Dr. Deville breaks down the latest advancements in radiation oncology for prostate cancer treatment, from cutting-edge proton therapy to modern precision-based methods designed to better target tumors while minimizing side effects. With more than 170 peer-reviewed publications and a career dedicated to advancing cancer care, he provides a clear look into how radiation therapy is evolving to improve patient outcomes.
Beyond the science, Dr. Deville also highlights his passion for Health Equity, Diversity, and Inclusion (HEDI), sharing his role on the ASTRO Council on HEDI and his recent election to the ASTRO Board of Directors.
Tune in to gain a deeper understanding of the future of prostate cancer treatment and how these innovations—and Dr. Deville’s leadership—are shaping a more effective and equitable approach to care.
www.prostatecancerrealtalk.com
32,140 Listeners
3 Listeners
11,935 Listeners
43,879 Listeners
111,150 Listeners
8,025 Listeners
25 Listeners
15,543 Listeners
52 Listeners
2,056 Listeners
19,791 Listeners
1,628 Listeners
11 Listeners